BRIEF published on 04/02/2025 at 07:35, 4 days 14 hours ago Sensorion Appoints Amit Munshi as Chairman of the Board Board Of Directors Hearing Loss Therapies Sensorion Leadership Amit Munshi Appointment Biotech Executive Experience
PRESS RELEASE published on 04/02/2025 at 07:30, 4 days 14 hours ago Inside Information / Other news releases Sensorion appoints Amit Munshi as Chairman of the Board and Independent Director, bringing extensive healthcare industry experience. Munshi to lead innovative therapeutic programs for hearing disorders Chairman Board Sensorion Amit Munshi Hearing Disorders
BRIEF published on 03/26/2025 at 07:35, 11 days 14 hours ago Sensorion joins the Van Lanschot Kempen conference in Amsterdam Investors Biotechnology Conference Sensorion Hearing Loss
PRESS RELEASE published on 03/26/2025 at 07:30, 11 days 14 hours ago Inside Information / Other news releases Sensorion announces participation at Van Lanschot Kempen Conference Life Sciences in Amsterdam on April 2-3, 2025. Company focuses on developing therapies for hearing loss disorders Life Sciences Sensorion Amsterdam Hearing Loss Therapies Van Lanschot Kempen Conference
BRIEF published on 03/14/2025 at 07:35, 23 days 14 hours ago Sensorion: 2024 Review and Outlook for 2025 Financial Results Investments SENS-401 SENS-501 Gene Therapies
PRESS RELEASE published on 03/14/2025 at 07:30, 23 days 14 hours ago Inside Information / News release on accounts, results Sensorion reports full-year 2024 results and provides corporate update with significant milestones achieved in gene therapy clinical trials and financial highlights. Company well positioned for growth in 2025 Clinical Trials Financial Highlights Gene Therapy Full-year Results Sensorion
BRIEF published on 03/07/2025 at 07:35, 30 days 14 hours ago Sensorion Completes Recruitment for NOTOXIS Trial of SENS-401 Clinical Trial Sensorion SENS-401 Cisplatin Ototoxicity
PRESS RELEASE published on 03/07/2025 at 07:30, 30 days 14 hours ago Inside Information / Other news releases Sensorion completes patient enrollment in NOTOXIS Phase 2a Clinical Trial of SENS-401 for Cisplatin-Induced Ototoxicity prevention, targeting a significant unmet medical need Clinical Trial Sensorion SENS-401 NOTOXIS Cisplatin-Induced Ototoxicity
BRIEF published on 02/21/2025 at 07:35, 1 month 13 days ago Sensorion's SENS-501 Clinical Trial Progresses with Positive DMC Recommendation Gene Therapy Clinical Trial Sensorion Hearing Loss SENS-501
PRESS RELEASE published on 02/21/2025 at 07:30, 1 month 13 days ago Inside Information / Other news releases Sensorion receives positive recommendation from Data Monitoring Committee for Audiogene Phase 1/2 clinical trial of SENS-501 gene therapy program to treat congenital deafness linked to OTOF gene mutations Gene Therapy Sensorion Audiogene Deafness Data Monitoring Committee
Published on 04/05/2025 at 01:50, 1 day 19 hours ago Battery X Metals Achieves Graphite Recovery Breakthrough in Partnership with Global Top 20 University in Controlled Trials
Published on 04/06/2025 at 18:20, 3 hours 23 minutes ago EQS-Adhoc: QIAGEN N.V.: QIAGEN announces strong preliminary Q1 2025 results and updates full-year 2025 adjusted earnings per share outlook
Published on 04/06/2025 at 15:09, 6 hours 35 minutes ago EQS-Adhoc: DEUTZ acquires developer of electrification solutions UMS
Published on 04/04/2025 at 18:51, 2 days 2 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/04/2025 at 18:30, 2 days 3 hours ago Forbo shareholders approved all proposals of the Board of Directors
Published on 04/04/2025 at 18:11, 2 days 3 hours ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 04/04/2025 at 19:18, 2 days 2 hours ago Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 18:17, 2 days 3 hours ago Reporting on share buyback transactions carried out between March 31 and April 3, 2025
Published on 04/04/2025 at 18:13, 2 days 3 hours ago Total number of voting rights and shares making up the share capital at March 31, 2025
Published on 04/04/2025 at 17:45, 2 days 3 hours ago imerys-04-04-2025-regulated-information-publication-of-the-meeting-notice
